Randomized Trial in Adult de Novo Ph Positive ALL With Chemotherapy, Imatinib or Ponatinib, Blinatumomab and SCT
Clinical trial NCT06061094 · RECRUITING
Trial details
- NCT number
- NCT06061094
- Sponsor
- Goethe University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-14
- Primary completion
- 2029-07-01
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.